Literature DB >> 19996952

Cerebrospinal fluid and spinal cord distribution of hyperbaric bupivacaine and baclofen during slow intrathecal infusion in pigs.

Sean H Flack1, Christopher M Bernards.   

Abstract

BACKGROUND: Despite the widespread use of implanted pumps for continuous intrathecal drug delivery, there have been no studies aimed at defining the effect of baricity and posture on drug distribution in the cerebrospinal fluid and spinal cord during the very slow infusion rates typically used for chronic intrathecal drug administration.
METHODS: Intrathecal microdialysis probes were placed at six points along the neuraxis in both the anterior and posterior intrathecal space of anesthetized pigs to permit cerebrospinal fluid sampling. Animals were then positioned either vertically or horizontally (prone), and a hyperbaric solution containing bupivacaine (7.5 mg/ml) and baclofen (2 mg/ml) was infused at 20 microl/h for 6 h, while the cerebrospinal fluid was collected for measurement of drug concentration. At the end of the experiment, the animals were killed, and the spinal cord was removed and divided into 1-cm sections that were further divided into anterior and posterior portions for measurement of drug concentration.
RESULTS: Bupivacaine and baclofen distribution was biased caudally in the vertical group and cephalad in the horizontal group. Drug concentration decreased rapidly in the cerebrospinal fluid and spinal cord as a function of distance from the site of administration in both groups, resulting in most drugs being located in very close proximity to the site of infusion.
CONCLUSION: Even at very slow infusion rates, drug distribution within the cerebral spinal fluid and spinal cord are affected by baricity/posture. These findings suggest that patient position and solution baricity may be important clinical factors determining the distribution and ultimate efficacy of chronic intrathecal drug infusions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19996952     DOI: 10.1097/ALN.0b013e3181c38da5

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  13 in total

1.  Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.

Authors:  D Dressler; S Berweck; A Chatzikalfas; M Ebke; B Frank; S Hesse; M Huber; J K Krauss; K-H Mücke; A Nolte; H-D Oelmann; P W Schönle; M Schmutzler; H Pickenbrock; C Van der Ven; N Veelken; M Vogel; T Vogt; F Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2015-07-16       Impact factor: 3.575

2.  Characteristics of distribution of morphine and metabolites in cerebrospinal fluid and plasma with chronic intrathecal morphine infusion in humans.

Authors:  Mark Wallace; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-19       Impact factor: 5.108

Review 3.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  Intrathecal baclofen therapy for treatment of spasticity in infants and small children under 6 years of age.

Authors:  Christian Hagemann; Ilka Schmitt; Grischa Lischetzki; Philip Kunkel
Journal:  Childs Nerv Syst       Date:  2019-08-09       Impact factor: 1.475

5.  Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular.

Authors:  Armaghan Emami; Jeff Tepper; Brian Short; Tony L Yaksh; Alison M Bendele; Thulasi Ramani; Alvaro F Cisternas; Jay H Chang; R Daniel Mellon
Journal:  Int J Toxicol       Date:  2017-12-21       Impact factor: 2.032

6.  Comparative pharmacokinetics of continuous and conventional intrathecal amphotericin B in rabbits.

Authors:  Min Fang; Tian Ming Lü; An De Ma; Li Wang; Guo Liang Li; Ai Zhu Qiu; Zhi Yong Pan; Yuan Yuan Wang; Xiao Jia Liu
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

Review 7.  Role of Catheter's Position for Final Results in Intrathecal Drug Delivery. Analysis Based on CSF Dynamics and Specific Drugs Profiles.

Authors:  De Andres Jose; Perotti Luciano; Villanueva Vicente; Asensio Samper Juan Marcos; Fabregat-Cid Gustavo
Journal:  Korean J Pain       Date:  2013-10-02

Review 8.  Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain.

Authors:  Gladstone C McDowell; Jason E Pope
Journal:  Neuromodulation       Date:  2016-02-09

9.  Palliative care with cervical intrathecal infusion and external pump for a late-stage cancer patient with refractory pain: A case report.

Authors:  Yanxin Ju; Demin Tian; Yanqin Tan; Zhijian Fu
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

10.  Alfentanil: correlations between absence of effect upon subcutaneous mast cells and absence of granuloma formation after intrathecal infusion in the dog.

Authors:  Tony L Yaksh; Joanne J Steinauer; Samantha L Veesart; Shelle A Malkmus
Journal:  Neuromodulation       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.